Gador is a leading Argentine pharmaceutical company. For the last 82 years, its mission has been to investigate, develop, manufacture and commercialize the best quality medicines for every patient at affordable prices. Gador continuously invests in product technology and quality control, according to international standards and maintains a large updated portfolio of pharmaceutical products. Our company is currently focused on biopharmaceutics as a source of innovation and generation of new therapeutic resources for its territory, which is expanded throughout Latin America. Gador has a longstanding experience in the commercialization of special products, either own products or licenses from world renowned companies, such as Gilead Sciences Ltd, Astellas Pharma, Eli Lilly, Coherus, Viatris, MSD, Novartis, Cipla, among others.
As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves:
Licenses of new products approved or at their last clinical development stage
Commercialization of a new-generation biosimilar
Development and commercialization of new biopharmaceuticals with focus in special products and rare disease
As a leader company in the market, Gador has undertaken an ambitious program in this area, which involves:
Licenses of new products approved or at their last clinical development stage
Commercialization of a new-generation biosimilar
Development and commercialization of new biopharmaceuticals with focus in special products and rare disease
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
